Status:
COMPLETED
Exclusive Enteral Nutrition for Remissionof Crohn's Diseases After Surgery
Lead Sponsor:
Jinling Hospital, China
Conditions:
Crohn Disease in Remission
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
For patients with Crohn's diseases undergoing surgery，whether postoperative exclusive enteral nutrition(EEN) could delay the endoscopic relapse needs exploration.The trial will investigate the efficac...
Eligibility Criteria
Inclusion
- \- CD patients who undergoing bowel resection with anastomosis
Exclusion
- patients who received stoma creation
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2023
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT05214430
Start Date
January 1 2020
End Date
July 31 2023
Last Update
October 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
General Surgery Institute,Jinling Hospital,Nanjing,Jiangsu,China
Nanjing, Jiangsu, China, 210000